measles vaccine + varicella vaccine + hepatitis A vaccine

This entry refers to a vaccination regimen consisting of three distinct vaccines: a measles vaccine (specifically the CAM-70 strain), a varicella vaccine, and a hepatitis A vaccine. These vaccines were evaluated in a Phase 4 observational study led by the University of the Witwatersrand in South Africa to assess their safety and immunogenicity in HIV-exposed and HIV-unexposed children. The measles vaccine is administered as a primary dose at 6 months and a booster at 12 months, while the varicella and hepatitis A vaccines are administered as single doses at 18 months. The vaccines used in the study are those currently licensed and approved for use in South Africa.

Other names

varicella vaccine-University of Witwatersrand, South Africa-measles-varicella-hepatitis AMeasles, Varicella, and Hepatitis-A Vaccines in HIV-exposed and Unexposed Children study vaccines